Stockreport

Two thirds of COVID-19 patients improve after Gilead drug: NEJM [Reuters (UK)]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Two thirds of COVID-19 patients improve after Gilead drug: NEJM - Reuters 3 Min Read (Reuters) - More than two-thirds of severely ill COVID-19 patients saw their conditi [Read more]